Title: Phytochemicals as adjuvants

Biography:

Shashikant  Vaidya, Department of Clinical Pathology at Haffkine Institute For Training, Research & Testing, India. His research interest is Clinical Immunology

Abstract

Adjuvants (ADJ) are the new technology in the search for new vaccines against challenging pathogens which are intracellular like Mycobacterium tuberculosis  and for vulnerable populations that respond poorly to traditional vaccines. ADJ  can improve immune responses in infants, the elderly and immuno-compromised. It is a substance added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immuno-stimulatory capabilities. The right match of antigens and ADJ can potentiate downstream adaptive immune responses, enabling the development of new efficacious vaccines.